Chemours Co Aktie
13,22 €
Deine Einschätzung
Chemours Co Aktie
Was spricht für und gegen Chemours Co in den nächsten Jahren?
Pro
Kontra
Rendite von Chemours Co im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Chemours Co | -5,21 % | -0,60 % | 26,34 % | -27,83 % | 29,81 % | -59,91 % | -39,90 % |
| Quaker Chemical Corp. | -0,75 % | -1,54 % | 8,47 % | -4,48 % | 5,79 % | - | - |
| Albemarle Corp | 4,33 % | -12,39 % | 13,84 % | 72,39 % | 13,43 % | -47,40 % | -0,48 % |
| Axalta Coating Systems Ltd. | -0,70 % | 0,00 % | 0,71 % | -18,50 % | 2,17 % | 1,44 % | 24,78 % |
Kommentare
News
This Chemicals Stock Is Down 32% but Just Became a Top 5 Holding After One Fund's $13 Million Bet
New York City-based Alta Fundamental Advisers initiated a new position in The Chemours Company (NYSE:CC), acquiring 800,000 shares valued at an estimated $12.67 million, according to a November 13
Luminus Trims Its Hefty Chemours Position
Luminus Management LLC reduced its stake in The Chemours Company (NYSE:CC) during Q3 2025, selling shares worth an estimated $4.30 million, based on the average quarterly price, according to an SEC
Chemours (CC) Q2 EPS Jumps 53%
Chemours (NYSE:CC), a global chemicals manufacturer known for its fluoroproducts and titanium dioxide pigments, announced its results for Q2 2025 on August 5, 2025. The most notable news was a solid



